Neal D. Freedman

Senior Investigator
Division of Cancer Epidemiology & Genetics, Metabolic Epidem
National Cancer Institute
United States of America

Scientist Medical Sciences
Biography

Dr. Freedman received his Ph.D. in biomedical sciences from the University of California, San Francisco in 2004 and a Masters in Public Health from the Harvard School of Public Health in 2005. He subsequently joined the Nutritional Epidemiology Branch of the Division of Cancer Epidemiology and Genetics as a Cancer Prevention Fellow, becoming a tenure-track investigator in 2009. Dr. Freedman was awarded scientific tenure by NIH in 2015, and is DCEG's principal investigator for the Prostate, Lung, Colon, and Ovary (PLCO) Cohort Study. He draws on his training in molecular biology and epidemiology to investigate the roles of tobacco, diet, and metabolic hormones in cancer risk.

Research Intrest

The role of tobacco and tobacco products in cancer and disease; Diet, energy balance, and liver cancer; Gastrointestinal conditions and hormones in cancer

List of Publications
Freedman ND, Ahn J, Hou L, Lissowska J, Zatonski W, Yeager M, Chanock SJ, Chow WH, Abnet CC. Polymorphisms in estrogen-and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis. 2008 Nov 17;30(1):71-7.
Freedman ND, Chow WH, Gao YT, Shu XO, Ji BT, Yang G, Lubin JH, Li HL, Rothman N, Zheng W, Abnet CC. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007 Jul 12.
Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology. 2009 Nov 1;50(5):1360-9.

Global Scientific Words in Medical Sciences